Bausch Health
BHC
#3706
Rank
NZ$4.85 B
Marketcap
$13.21
Share price
1.08%
Change (1 day)
11.45%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.70. In 2022 the company made an earnings per share (EPS) of -$1.10 an increase over its 2021 EPS that were of -$4.70.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29290.54%
2022-$1.10-76.64%
2021-$4.7068.45%
2020-$2.79-68.91%
2019-$8.97-57.11%
2018-$20.92-272.22%
2017$12.15-199.29%
2016-$12.24798.7%
2015-$1.36-128.31%
2014$4.81-204.62%
2013-$4.60602.7%
2012-$0.65-171.15%
2011$0.92-143.96%
2010-$2.09-206.57%
2009$1.96-11.2%
2008$2.212.46%
2007$2.16-7.58%
2006$2.33-14.29%
2005$2.7254%
2004$1.77-500%
2003-$0.44-141.67%
2002$1.06-4.76%
2001$1.11-175%
2000-$1.49-268%
1999$0.8814.94%
1998$0.7720.83%
1997$0.6453.83%
1996$0.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.77-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA